Vivek Subbiah: Our latest commentary on Pediatric AML Trials – OncoDaily
Vivek Subbiah: Our latest commentary on Pediatric AML Trials / Branko Cuglievan, cancer, Nature Reviews Clinical Oncology, OncoDaily, Oncology, Pediatric AML
Related Articles
Access CNN Live TV channels. | CNN
Customers of eligible partners can watch live TV on CNN at no additional cost.
Trump Seeks, Without Evidence, to Blame D.E.I. and Democrats for the Crash
President Trump’s remarks, suggesting that diversity in hiring and other Biden administration policies somehow caused the disaster, reflected his instinct to immediately frame major events…
Understanding of Clinical Trials Among Patients With Cancer and Their Relatives
This survey study evaluates the knowledge, perceptions, and motivations among patients with cancer and their relatives in Turkey regarding participation in clinical trials of cancer…
Trastuzumab emtansine as second-line therapy in HER2 positive advanced biliary tract cancers: Single arm prospective phase II clinical trial (TAB-3 trial).
584Background: HER2 overexpression or amplification is a therapeutic target of interest in advanced BTC, especially gallbladder cancers (GBC). Limited studies evaluate the role of T-DM1…
Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study – PubMed
Ministry of Health and Welfare of Taiwan.
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial
PURPOSEMobocertinib is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that targets EGFR exon 20 insertion (ex20ins) mutations in non–small cell lung cancer…
Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective
Experimental & Molecular Medicine – In the intricate realm of health issues, there’s a serious inflammation-related disorder known as secondary hemophagocytic lymphohistiocytosis, which…
